NumFin

JW Pharmaceutical Corporation

符号: 001065.KS

KSC

29450

KRW

今天的市场价格

  • 18.2050

    市盈率

  • -0.5003

    PEG比率

  • 708.70B

    MRK市值

  • 0.01%

    DIV收益率

JW Pharmaceutical Corporation (001065-KS) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 JW Pharmaceutical Corporation (001065.KS). 的默认数据。公司收入显示 493894.037 M 的平均值，即 0.049 % 增长率。整个期间的平均毛利润为 188837.426 M，即 0.108 %. 平均毛利率为 0.380 %. 公司去年的净收入增长率为 0.160 %，等于 1.016 % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 JW Pharmaceutical Corporation 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.027. 在流动资产领域，001065.KS 的报告货币为378091.35. 这些资产中的很大一部分，即 92838.028 是现金和短期投资。与去年的数据相比，该部分的变化率为-0.380%. 公司的长期投资虽然不是其重点，但以报告货币计算的52498.157（如果有的话）为52498.157。这表明与上一报告期相比，-164.372% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 30000. 这一数字表明，-0.187% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 265440.456. 这方面的年同比变化率为 0.104%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为173629.306，存货估值为 106091.35，商誉估值为 1404.47（如有. 无形资产总额（如果有）按 28951.95 估值. 应付账款和短期债务分别为 73847.21 和 117404.62. 债务总额为170280.44，债务净额为 154371.57. 其他流动负债为 89585.37，加上总负债 379598.34. 最后，如果存在推荐股票，则其估值为 3173.63.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

370559.8492838149678.765666.1
55291.2
41864.3
30948.4
32096.8
39273.8
8213.6
5702.7
2781.2
3963.3
3369.9
9770.4
20102
18622.8
17984

balance-sheet.row.short-term-investments

282046.7176929.2115780.832299.6
44839.8
-37274.1
0
0
20
30
730.7
1829.1
1579.7
1313
1134.3
8739.7
4519.7
3111.6

balance-sheet.row.net-receivables

692398.22173629.3162146.2192840
132743.5
189013.4
234798.7
272643.3
285781.7
285524.1
271327.6
246200.4
0
313543.6
156458.7
0
0
93464.5

balance-sheet.row.inventory

456503.25106091.4111668.4102527.6
101197.8
90442.5
101367.1
106626.8
97585.5
82436.7
71346.4
75113.1
70137.9
85916.6
90742
98580.7
76356.5
55112.1

balance-sheet.row.other-current-assets

11337.775532.71963.75417.8
10096.3
13737.3
6795.8
0
0
0
0
0
0
0
0
0
0
17123.2

balance-sheet.row.total-current-assets

1530799.07378091.4425457.1366451.5
299328.7
335057.5
373910.1
411366.9
422640.9
376174.4
348376.6
324094.7
331899.8
402830.1
256971.1
256908.1
227136.7
183683.9

balance-sheet.row.property-plant-equipment-net

624681155723.7123048.1118392.3
185571.7
150429.7
117770.2
122119.5
126961.2
129725.4
136287.4
144078.6
151903.1
234874
229170.4
206463.5
154689.7
65156.2

balance-sheet.row.goodwill

11794.821404.500
0
7049.5
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

92583.312895216266.221473.1
17666.1
14346.1
15137.1
20136.7
23391
28555.6
29924.2
28055
24986.3
22823.4
26013.6
18617.5
17703.3
17758.3

balance-sheet.row.goodwill-and-intangible-assets

104378.1330356.416266.221473.1
17666.1
21395.6
15137.1
20136.7
23391
28555.6
29924.2
28055
24986.3
22823.4
26013.6
18617.5
17703.3
17758.3

balance-sheet.row.long-term-investments

20291.5352498.2-8155469814.7
-21069.5
46474.8
0
72715.1
10298.4
10694.3
9837.8
6433.6
3272.3
2514.6
3444.7
-5277.2
2513
24947.3

balance-sheet.row.tax-assets

89655.8620623.321811.320802.2
17979.9
19850.3
10196.7
4534.8
2494.4
2605.5
69693.5
86706.6
91083.8
0
5365.8
2792.3
3243.3
1467

balance-sheet.row.other-non-current-assets

261266.167745.9122944.136119.4
49608
0
76777
72715.1
65291.8
65725.9
69693.5
86706.6
91083.8
4049.6
10668.9
18732.9
14496.4
11238.6

balance-sheet.row.total-non-current-assets

1100272.68266947.4202515.7266601.6
249756.3
238150.4
219881.1
219506.2
228436.9
237306.6
245742.9
265273.8
271245.5
264261.6
274663.4
241329
192645.6
120567.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

2631071.75645038.8627972.8633053.1
549085
573207.9
593791.2
630873.1
651077.8
613481
594119.5
589368.5
603145.3
667091.7
531634.5
498237.1
419782.3
304251.2

balance-sheet.row.account-payables

262951.7173847.282907.951642.9
47885.4
45087.2
44464.6
59586.1
59395.3
36185.4
33750.6
32167.6
32325.4
39714.4
30695.7
29459.4
35389.9
24947.7

balance-sheet.row.short-term-debt

667547.61117404.6207693123074.6
107315.7
155880.8
128031
176857.3
163002.5
189958.6
145009.5
261275.8
233972.6
251907.7
85352.2
77800
109100
49900

balance-sheet.row.tax-payables

57750.4111113.513983.929008.6
4415.7
3098.5
8691.8
4137.1
2521.9
2288.5
3979.6
1271.9
9944.1
2497.8
3437.6
6414.1
6978.9
11711.6

balance-sheet.row.long-term-debt-total

197297.36300001849.3122070.1
74904.5
31646.3
47188.6
13500
49404.2
100553.2
132496.1
52588.7
124215.6
165041.6
179361.2
143573.2
40194
55000

Deferred Revenue Non Current

1431.951325.40-13199.8
-20534.7
-19026.1
199.2
0
0
0
23348.8
15170.1
13252.1
0
7610.2
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

5294.44---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

206288.7489585.482814.935045.6
42299.9
37271.2
47181.1
38093.7
35577.6
34637.3
32675.4
22836.1
31556
26559.9
25387.4
37321.1
42579.1
32958.5

balance-sheet.row.total-non-current-liabilities

309778.2292671.222082.6161836
106870.5
65132.7
105311.6
85559.5
116789.3
127293.1
158856.5
72349.8
141628.6
178658.9
201616
165706.5
56469.1
69655.7

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

112201.2922875.83102.62600.9
2169
2391.9
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

1624750.34379598.3402213.7444513.6
341618.2
343116
333680.1
360096.6
374764.7
388074.3
370291.9
388629.3
439482.6
496840.9
343051.3
310287
243538.1
177461.8

balance-sheet.row.preferred-stock

15209.453173.639733352.6
3315.7
3296.8
3284.4
3272.2
3260.3
572.9
3875.3
519.9
495.2
471.7
457.9
444.6
431.7
419.1

balance-sheet.row.common-stock

229188.6757925.955445.253849.8
52300.1
50795.1
49513.7
47878.1
46856.7
44627.3
37657.9
34492
28459.8
25047.3
24028.8
23328.9
22601.7
21943.4

balance-sheet.row.retained-earnings

391080.629261289129.858594.7
65083.9
71819.4
107391.2
26001.5
33223.2
51360.5
58409.5
62918.3
62107.9
85566.2
55479.6
52735.4
44584
82894.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

82131.3953896.251771.852070.7
51143.9
50788.1
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

303426.9857832.740034.333327
35647.4
53382.3
99921.9
193624.7
192973
128845.9
123884.8
102809
72599.8
59165.7
108616.9
111441.1
108626.9
21532.6

balance-sheet.row.total-stockholders-equity

1021037.11265440.5240354.1201194.8
207490.9
230081.7
260111.1
270776.5
276313.2
225406.7
223827.6
200739.3
163662.7
170250.8
188583.2
187950.1
176244.2
126789.4

balance-sheet.row.total-liabilities-and-stockholders-equity

2631071.75645038.8627972.8633053.1
549085
573207.9
593791.2
630873.1
651077.8
613481
594119.5
589368.5
603145.3
667091.7
531634.5
498237.1
419782.3
304251.2

balance-sheet.row.minority-interest

-14715.710-14595.1-12655.2
-24
10.1
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

1006321.4265440.5225759188539.5
207466.9
230091.8
260111.1
270776.5
276313.2
225406.7
223827.6
200739.3
163662.7
170250.8
188583.2
187950.1
176244.2
126789.4

balance-sheet.row.total-liabilities-and-total-equity

2631071.75---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

302338.24129427.334226.8102114.3
23770.3
9200.7
12884.4
9925.7
10318.4
10724.3
10568.5
8262.7
4852
3827.6
4579
3462.5
7032.7
28058.9

balance-sheet.row.total-debt

887720.78170280.4209542.3245144.7
182220.2
187527.1
175219.6
190357.3
212406.8
290511.8
277505.6
313864.4
358188.3
416949.3
264713.5
221373.2
149294
104900

balance-sheet.row.net-debt

799207.66154371.6175644.4211778.2
171768.9
145662.9
144271.2
158260.5
173153
282328.2
272533.6
312912.4
355804.6
414892.4
256077.4
210010.9
135190.9
90027.6

现金流量表

在 JW Pharmaceutical Corporation 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.005 的转变。该公司最近通过发行 -3872.98 扩大了股本，与上一年相比出现了4.474 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-63834269762.000. 与上一年相比， 2.374 发生了变化. 在同一时期，公司记录了 22444.6, -17093.12 和 -28189.8，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-8813.67 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -54，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

37151.213509629852.6-1441.5
-15275.5
-25275
8056.9
-742.5
-10933.5
1961.4
1446.9
2274.9
-20393.6
-9803.6
5600.3
10918.7
6433.2
8761

cash-flows.row.depreciation-and-amortization

22574.622444.616836.316111.7
20688.2
20349.1
17682.3
18789.4
18645.8
17863.1
16617
16153.1
14358.5
12839.7
9037.7
10430
12454.1
12649.3

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-20262.51-20262.5-6169.7-46055.8
35217.3
62912.5
-393.6
-15515.9
-14565.9
-37919.7
-19853.9
-5773.8
53254.3
-31111.6
-44929.7
-53964.1
-41256.1
-29804.6

cash-flows.row.account-receivables

-3162.23-3162.2-4352.5-41296.6
45698.5
38275.3
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

8916.88916.8-11541.3-2655.1
-8876.5
19783.5
-5784.1
-11120.8
-16671.5
-11970.4
4258.7
-5513.5
16310.7
4250.5
7838.7
-22224.2
-21244.4
-9480.9

cash-flows.row.account-payables

-9535.56-9535.631652.33729.7
2831.1
-632.9
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-16481.52-16481.5-21928.1-5833.7
-4435.9
5486.5
5390.5
-4395.1
2105.6
-25949.3
-24112.7
-260.3
36943.6
-35362.1
-52768.4
-31740
-20011.7
-20323.7

cash-flows.row.other-non-cash-items

47693.9449879.116245.249509.5
22424.4
-2455.4
26764.4
30919.1
13592.3
13920.2
9069.2
6070.3
16995.5
9891.8
18612.5
21496.7
21020.8
23212.9

cash-flows.row.net-cash-provided-by-operating-activities

87157.24000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-38561.91-42967.2-12352.5-12901.6
-15039.1
-13096.4
-8345
-10950.9
-10021.4
-9112.3
-12021.7
-10567.4
-20100
-21077.2
-39448.4
-68231.9
-37745.4
-15830.4

cash-flows.row.acquisitions-net

-14325.59-12034-40.9385
-5625
-5349.1
-5178.9
0
-1616.1
3555.9
18243.2
-6249.5
-1967
-9916.9
-9009.3
-2003.6
-3064.5
-1000

cash-flows.row.purchases-of-investments

-61344-61344-73817.4-140023.5
-56346.6
-15471
644.4
0
-58045
-660
-2510
-30
-162
-226
-22651
-600
-2336.6
-93521.5

cash-flows.row.sales-maturities-of-investments

69604.036960447473.7141101.7
16.6
12000
140
20
60152
760.7
1398.4
385.5
272.2
673.4
31363.3
2458.5
1684
91776.4

cash-flows.row.other-investing-activites

-19152.8-17093.119817.9-11430.8
-2433.2
-67.2
-1178.9
1040
760.7
-1890.9
5712.8
6284.9
2140.7
11338.9
9816.5
5051.6
4224
-597.3

cash-flows.row.net-cash-used-for-investing-activites

-63780.27-63834.3-18919.2-22869.2
-79427.3
-21983.7
-13918.4
-9890.9
-8769.9
-7346.6
10822.6
-10176.5
-19816.1
-19207.7
-29928.8
-63325.4
-37238.6
-19172.8

cash-flows.row.debt-repayment

-216351.12-28189.8-177004.4-98658.1
-169308.3
-158874.8
-200136.5
-197214.2
-186629.7
-154903.2
-173303.2
-149047.2
-104907
-489629.1
-382757.8
-70000
-20000
-520300.3

cash-flows.row.common-stock-issued

7880.94-387310000398.5
0
166765.4
184829.1
466
224077.3
8299.9
5900
10000
12975
1852.4
424555.8
0
0
528600

cash-flows.row.common-stock-repurchased

-260.87-260.9-281.6-412.3
-224.2
-258.5
-9370.6
-317.3
-218.6
-37.7
-42.8
-40.1
-44.3
-46.3
-60.2
0
0
-2102.9

cash-flows.row.dividends-paid

0-8813.7-7352-7149.5
-6953.8
-6815.5
-6510.3
-5884.4
-2711.7
-2694.4
-1752.5
-1449.6
-2043.5
-2940.7
-2856.1
-2767.2
-2686.7
-2974.4

cash-flows.row.other-financing-activites

176299.39-54137730.5133023
162476.9
-24976.9
-10000.2
175075.2
-691.9
164011.3
155129.6
130578.9
50000
521404.3
0
144470.7
60504
-250.5

cash-flows.row.net-cash-used-provided-by-financing-activities

-41245.33-41191.3-36907.527201.6
-14009.4
-24160.3
-41188.5
-27874.6
33825.4
14676
-14068.8
-9958
-44019.8
30640.6
38881.7
71703.4
37817.3
2971.8

cash-flows.row.effect-of-forex-changes-on-cash

-120.69-120.7-406.4458.7
-1030.6
1528.8
1848.5
-2841.6
-724
57.2
-13
-21.7
-52.1
-4.9
0
0
0
-1007.3

cash-flows.row.net-change-in-cash

-17989.06-17989.1531.422915.1
-31412.9
10915.8
-1148.4
-7157
31070.2
3211.6
4019.9
-1431.6
326.8
-6755.6
-2726.3
-2740.8
-769.3
-2389.6

cash-flows.row.cash-at-end-of-period

88513.1315908.933897.933366.5
10451.3
41864.3
30948.4
32096.8
39253.8
8183.6
4971.9
952.1
2383.7
2056.9
8636
11362.4
14103.1
14872.4

cash-flows.row.cash-at-beginning-of-period

106502.1833897.933366.510451.3
41864.3
30948.4
32096.8
39253.8
8183.6
4971.9
952.1
2383.7
2056.9
8812.6
11362.4
14103.1
14872.4
17262

cash-flows.row.operating-cash-flow

87157.2487157.256764.418124
63054.4
55531.1
52109.9
33450.2
6738.6
-4174.9
7279.1
18724.5
64214.8
-18183.7
-11679.2
-11118.8
-1348
14818.6

cash-flows.row.capital-expenditure

-38561.91-42967.2-12352.5-12901.6
-15039.1
-13096.4
-8345
-10950.9
-10021.4
-9112.3
-12021.7
-10567.4
-20100
-21077.2
-39448.4
-68231.9
-37745.4
-15830.4

cash-flows.row.free-cash-flow

48595.334419044411.95222.4
48015.3
42434.7
43764.9
22499.3
-3282.8
-13287.3
-4742.6
8157.1
44114.8
-39260.9
-51127.5
-79350.7
-39093.4
-1011.7

利润表行

JW Pharmaceutical Corporation 的收入与上期相比变化了 0.094%。据报告, 001065.KS 的毛利润为 335672.4。该公司的营业费用为 238911.37，与上年相比变化了 6.100%. 折旧和摊销费用为 22444.6，与上一会计期间相比变化了 0.147%. 营业费用报告为 238911.37，显示6.100% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0，同比增长0.537%. 营业收入为 96761.03，与上年相比变化了0.537%. 净利润的变化率为 0.160%。去年的净收入为37006.33.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

748526.71748526.7684351.1606584.9
547335.7
511335.3
537182
502918.6
467465.1
434352.4
412791.2
394182.3
397084.8
431007.3
443275.7
455146.9
437648.4
385010.3

income-statement-row.row.cost-of-revenue

412984.31412854.3396396.6372208.6
369810.1
350216
340141.8
314286.1
294121.4
273729.1
261517.6
249698.7
268107.3
283012.6
281782.9
269092.2
246934
202053.2

income-statement-row.row.gross-profit

335542.4335672.4287954.5234376.3
177525.6
161119.4
197040.2
188632.4
173343.7
160623.3
151273.6
144483.6
128977.5
147994.7
161492.8
186054.7
190714.4
182957.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

33671.36---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

204703.62---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

35443.42---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-253431.49-36136.864701.467954.7
63385.9
73201.2
881.2
1952.4
-1558.5
523.1
-49.9
1331.6
333.5
73.2
-8420.9
-9672.5
-9557
-10072.2

income-statement-row.row.operating-expenses

-2317.17238911.4225175.5203176.5
178848.6
180133.2
175456.1
166914.3
148805.8
139098.5
133163.7
118583.5
119491.4
131510.5
132329.4
148872.9
154043.4
141696.2

income-statement-row.row.cost-and-expenses

474255.45651765.7621572575385.1
548658.7
530349.2
515597.9
481200.5
442927.2
412827.6
394681.3
368282.3
387598.7
414523.1
414112.3
417965.1
400977.4
343749.3

income-statement-row.row.interest-income

5893.155893.15321.51654.8
628.7
128
9.2
114.7
560.6
1054.1
571.3
1584
167.1
170.4
1176.8
1291.3
1908
1319.3

income-statement-row.row.interest-expense

9617.0412561.79386.87336.7
7587.1
11278.5
8688
8880.1
12114.5
14279.7
17282.2
20653
24391.7
24836.2
17251.4
13089
9020.1
6965.4

income-statement-row.row.selling-and-marketing-expenses

35443.42---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-45650.78-42545.6-17598.9-10667.2
-7729.2
-15321.4
-11349.9
-23066.2
-17456.6
-19468.1
-16249.1
-22493.9
-24637.9
-27967
-20235.4
-20861.4
-17354
-19814.7

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-253431.49-36136.864701.467954.7
63385.9
73201.2
881.2
1952.4
-1558.5
523.1
-49.9
1331.6
333.5
73.2
-8420.9
-9672.5
-9557
-10072.2

income-statement-row.row.total-operating-expenses

-45650.78-42545.6-17598.9-10667.2
-7729.2
-15321.4
-11349.9
-23066.2
-17456.6
-19468.1
-16249.1
-22493.9
-24637.9
-27967
-20235.4
-20861.4
-17354
-19814.7

income-statement-row.row.interest-expense

9617.0412561.79386.87336.7
7587.1
11278.5
8688
8880.1
12114.5
14279.7
17282.2
20653
24391.7
24836.2
17251.4
13089
9020.1
6965.4

income-statement-row.row.depreciation-and-amortization

179363.7922444.619571.516180.7
20688.2
16529.5
17682.3
18789.4
18645.8
17863.1
16617
16153.1
14358.5
12839.7
9037.7
10430
12454.1
12649.3

income-statement-row.row.ebitda-caps

279325.21---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

99961.429676162960.931199.8
-5476
-19013.8
21584.1
21718.1
24537.9
21524.8
18110
25900
9486.1
16623.3
29163.3
37181.7
36671
41260.9

income-statement-row.row.income-before-tax

54310.6454215.44536220532.7
-13205.2
-34335.2
10234.2
-1348
7081.3
2056.6
1860.9
3406.1
-15151.8
-11482.8
8927.9
16320.3
19317
21446.2

income-statement-row.row.income-tax-expense

16406.1916406.215509.421974.1
2070.3
-9060.2
2177.3
-605.6
18014.9
95.2
414
1131.3
5241.8
-1679.2
3327.6
5401.6
12883.8
12685.2

income-statement-row.row.net-income

37006.3337006.331891.7-1441.5
-15275.5
-25275
8056.9
-742.5
-10933.5
1961.4
1446.9
2274.9
-20393.6
-9803.6
5600.3
10918.7
6433.2
8761
类似股票
您可能还对以下内容感兴趣：
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
TLLTF
TILT Holdings Inc..
0.0332 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
551.15 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
869.7 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.616 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1024.3 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC

常见问题

什么是 JW Pharmaceutical Corporation (001065.KS) 总资产是多少？

JW Pharmaceutical Corporation (001065.KS) 总资产为 645038796101.000.

什么是企业年收入？

年收入为 389220837356.000.

企业利润率是多少？

公司利润率为 0.448.

什么是公司自由现金流？

自由现金流为 2124.292.

什么是企业净利润率？

净利润率为 0.049.

企业总收入是多少？

总收入为 0.134.

什么是 JW Pharmaceutical Corporation (001065.KS) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 37006333990.000.

公司总债务是多少？

债务总额为 170280439662.000.

营业费用是多少？

运营支出为 238911370958.000.

公司现金是多少？

企业现金为 15908868301.000.